During the term of the agreement, the retailer will have the exclusive rights to distribute Derma Sciences’s Medihoney antimicrobial products at retail throughout Canada. The $2 million per
Under the secured loan agreement, Somaxon borrowed $15 million from the lenders. The loan is secured by a first priority security interest in all of the company’s assets,
Animal reproductive toxicity studies recently completed with RDEA806 have demonstrated no effects on male or female fertility or on early embryonic development at all tested doses. These results
The interim results of this Phase I/II study of targeted gene delivery in vivo are very encouraging – intravenous infusions of Rexin-G demonstrated significant biological activity without toxicity
This patent adds to the intellectual property surrounding Aveo’s proprietary and cancer biology platform. Tuan Ha-Ngoc, president and CEO of Aveo, said: “We are very pleased to receive
STEMPRO mesenchymal stem cells (MSC) serum free media (SFM) is a first of its kind product that overcomes many challenges in MSC culture. In addition to launching Stempro
As a result of the agreement, a team of Stanford graduate students will be working to extend Tibion’s technology platform to additional medical applications. The work will serve
Seahorse extracellular flux (XF) analyzers provide method to non-invasively measure the two major energy producing pathways – mitochondrial respiration and glycolysis – in living cells. The microplate-based technology
The first of these studies, a Phase II trial, evaluated the effects of an oral formulation of Relistor for the treatment of opioid-induced constipation (OIC), in patients with
Sanwa will use these customized ES cell assays to identify and screen new diabetes drug candidates. The assay systems were developed to expand the capabilities of VistaGen’s ES
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.